Skip to main content
. Author manuscript; available in PMC: 2023 Jul 14.
Published in final edited form as: Anal Methods. 2016 Mar 3;8(14):2880–2886. doi: 10.1039/c6ay00107f

Figure 5: Lysis of RSV in Tris and human nasal sample matrix with thermal cycler and chemical heater heat deactivation.

Figure 5:

Equal concentrations of RSV in Tris buffer or human nasal sample matrix were lysed for 5 minutes then analyzed by qRT-PCR. Output is reported by percent amplifiable RNA, with thermal cycler data set to 100%. Data is mean ± one standard deviation, n=6 for Tris Buffer, n=5 for clinical sample.